Elimination of 51Cr-labelled target cells as a method of in vivo assessment of immune reactions. 1981

L Makowka, and R E Falk, and J A Falk, and J Teodorczyk-Injeyan, and N A Nossal, and L E Rotstein

This report describes the use of an in vivo 51Cr release assay which is able to monitor various immune reactions in the rat. This assay is able to quantitate the immune response to tumour and also to assess the relative efficacy of different immunostimulants in this tumour model. These data correlate well with survival studies in tumour-bearing rats. This assay can also measure the sensitizing effect of antigens from animals differing at both the major and minor histocompatibility locus using various routes of sensitization and various donor tissues. Allograft survival can also be correlated to in vivo 51Cr release. This method is both reproducible and specific. The in vivo 51Cr release assay is a useful and versatile means of monitoring the development of antitumour responses and the degree of sensitization to histocompatibility antigens in a variety of situations in the rat. It may therefore prove useful as a rapid method for screening new antitumour and immunosuppressive regimens to be used in various studies.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008297 Male Males
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D011108 Polymers Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS). Polymer
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D011917 Rats, Inbred Lew An inbred strain of rat that is used in BIOMEDICAL RESEARCH. Rats, Inbred Lewis,Rats, Lew,Inbred Lew Rat,Inbred Lew Rats,Inbred Lewis Rats,Lew Rat,Lew Rat, Inbred,Lew Rats,Lew Rats, Inbred,Lewis Rats, Inbred,Rat, Inbred Lew,Rat, Lew
D002860 Chromium Radioisotopes Unstable isotopes of chromium that decay or disintegrate emitting radiation. Cr atoms with atomic weights of 46-49, 51, 55, and 56 are radioactive chromium isotopes. Radioisotopes, Chromium
D005260 Female Females
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft

Related Publications

L Makowka, and R E Falk, and J A Falk, and J Teodorczyk-Injeyan, and N A Nossal, and L E Rotstein
October 1975, Journal of immunological methods,
L Makowka, and R E Falk, and J A Falk, and J Teodorczyk-Injeyan, and N A Nossal, and L E Rotstein
January 1970, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology,
L Makowka, and R E Falk, and J A Falk, and J Teodorczyk-Injeyan, and N A Nossal, and L E Rotstein
June 1974, Transplantation,
L Makowka, and R E Falk, and J A Falk, and J Teodorczyk-Injeyan, and N A Nossal, and L E Rotstein
January 1986, Allergie und Immunologie,
L Makowka, and R E Falk, and J A Falk, and J Teodorczyk-Injeyan, and N A Nossal, and L E Rotstein
July 1994, Clinical and experimental pharmacology & physiology,
L Makowka, and R E Falk, and J A Falk, and J Teodorczyk-Injeyan, and N A Nossal, and L E Rotstein
August 1977, Cellular immunology,
L Makowka, and R E Falk, and J A Falk, and J Teodorczyk-Injeyan, and N A Nossal, and L E Rotstein
May 1956, Clinical science,
L Makowka, and R E Falk, and J A Falk, and J Teodorczyk-Injeyan, and N A Nossal, and L E Rotstein
March 1966, Transplantation,
L Makowka, and R E Falk, and J A Falk, and J Teodorczyk-Injeyan, and N A Nossal, and L E Rotstein
January 1980, Folia biologica,
L Makowka, and R E Falk, and J A Falk, and J Teodorczyk-Injeyan, and N A Nossal, and L E Rotstein
July 1986, Clinical science (London, England : 1979),
Copied contents to your clipboard!